Why must Olympic athletes prove that they have asthma to be permitted to take inhaled β2-agonists?

被引：9

作者：

Weiler, JM ^{[1
]}

机构：

[1] Univ Iowa, Iowa City, IA 52242 USA

来源：

JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY | 2003年 / 111卷 / 01期

关键词：

D O I：

10.1067/mai.2003.113

中图分类号：

R392 [医学免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：36 / 37

页数：2

共 50 条

[1] Diagnosis of asthma and permitted use of inhaled β2-agonists in athletes
Bonini, S
Brusasco, V
Carlsen, KH
Delgado, L
Giacco, SD
Haahtela, T
Rasi, G
van Cauwenberge, PB
ALLERGY, 2004, 59 (01) : 33 - 36
[2] Diagnosis of asthma and permitted use of inhaled β2-agonists in athletes (vol 59, pg 33, 2004)
Bonini, S
Brusasco, V
Carlsen, KH
Delgado, L
Del Giacco, SR
Haahtela, T
Rasi, G
Cauwenberge, PB
ALLERGY, 2005, 60 (04) : 548 - 548
[3] Clinical concerns with inhaled β2-agonists -: Adult asthma
Cockcroft, D. W.
CLINICAL REVIEWS IN ALLERGY & IMMUNOLOGY, 2006, 31 (2-3) : 197 - 207
[4] Do inhaled β2-agonists have an ergogenic potential in non-asthmatic competitive athletes?
Kindermann, Wilfried
SPORTS MEDICINE, 2007, 37 (02) : 95 - 102
[5] Long-acting inhaled β2-agonists in asthma therapy
Moore, RH
Khan, A
Dickey, BF
CHEST, 1998, 113 (04) : 1095 - 1108
[6] Step one for asthma treatment -: β2-agonists or inhaled corticosteroids?
Redington, AE
DRUGS, 2001, 61 (09) : 1231 - 1238
[7] Step One for Asthma Treatmentβ2-Agonists or Inhaled Corticosteroids?
Anthony E. Redington
Drugs, 2001, 61 : 1231 - 1238
[8] Ergogenic Effects of Inhaled β2-Agonists in Non-Asthmatic Athletes
Wolfarth, Bernd
Wuestenfeld, Jan C.
Kindermann, Wilfried
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2010, 39 (01) : 75 - +
[9] Short-acting inhaled β2-agonists: why, whom, what, how?
Emeryk, Andrzej
Emeryk-Maksymiuk, Justyna
ADVANCES IN RESPIRATORY MEDICINE, 2020, 88 (05) : 443 - 449
[10] Inhaled corticosteroids plus long-acting β2-agonists as a combined therapy in asthma
García-Marcos, L
Schuster, A
Barroso, NC
EXPERT OPINION ON PHARMACOTHERAPY, 2003, 4 (01) : 23 - 39

← 1 2 3 4 5 →